Investments in speculative biotech can cover lots of ground in the healthcare arena. From looking for a cure to cancer, all the way to weight management, there is a never ending supply of companies attempting to change the world of healthcare. Most are risky investments at best as these companies navigate through the maze or FDA regulations and clinical trials, while trying to keep their heads above water financially. This is where we find one special company named Advanced Cell Technology (ACTC.OB).
At first glance it does not seem to have much investment potential. With a current market capitalization of only $180 million, ACTC is definitely not an investment for the timid. That being the case, there are two critical...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|